NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
35.26
-0.59 (-1.65%)
At close: Dec 5, 2025, 4:00 PM EST
35.00
-0.26 (-0.74%)
After-hours: Dec 5, 2025, 6:50 PM EST
NAMS Market Cap
NAMS has a market cap or net worth of $4.00 billion as of December 5, 2025. Its market cap has increased by 75.49% in one year.
Market Cap
4.00B
Enterprise Value
3.24B
1-Year Change
75.49%
Ranking
Category
Stock Price
$35.26
Market Cap Chart
Since February 8, 2021, NAMS's market cap has increased from $154.45M to $4.00B, an increase of 2,488.65%. That is a compound annual growth rate of 96.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 4.07B | 47.75% |
| Dec 31, 2024 | 2.75B | 199.19% |
| Dec 29, 2023 | 919.56M | 3.44% |
| Dec 30, 2022 | 889.00M | 537.58% |
| Dec 31, 2021 | 139.43M | -9.72% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.09B |
| Johnson & Johnson | 487.23B |
| AbbVie | 401.00B |
| UnitedHealth Group | 299.89B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 248.75B |
| Abbott Laboratories | 218.02B |